Gold bars to be exempt from tariffs, White House clarifies
In a recent filing with the Securities and Exchange Commission, Accolade, Inc. (NASDAQ:ACCD) disclosed that Colin McHugh, the company's Chief Accounting Officer, sold a portion of his holdings in the company. The transaction, dated January 3, 2025, involved the sale of 524 shares of common stock at an average price of $3.407 per share, totaling approximately $1,785. The stock, currently trading at $3.5, has experienced significant volatility over the past year, with shares down 69% from their 52-week high of $15.36.
The filing also reported that McHugh executed transactions on January 2, 2025, involving the conversion of restricted stock units (RSUs) into common stock. This conversion added a total of 1,534 shares to his direct ownership. However, it's important to note that the sale of shares on January 3 was conducted to cover tax withholding obligations related to these RSU transactions, as indicated in the filing's footnotes. According to InvestingPro, Accolade maintains strong liquidity with a current ratio of 2.72, and investors should note the company's upcoming earnings report in just 3 days. For deeper insights into insider trading patterns and comprehensive financial analysis, InvestingPro offers detailed research reports covering over 1,400 US stocks.
Following these transactions, McHugh holds 62,066 shares of Accolade's common stock, representing a stake in the company's $281 million market capitalization.
In other recent news, Accolade Inc (NASDAQ:ACCD). has been the subject of several analyst adjustments following its strong second-quarter 2025 financial performance, which yielded a total revenue of $106.4 million, surpassing expectations. Wells Fargo (NYSE:WFC), Stephens, Canaccord Genuity, Truist Securities, and BofA Securities have all revised their price targets for Accolade, with Wells Fargo and Stephens maintaining Equal Weight and Overweight ratings, respectively, while the others continue to hold Buy ratings. The analysts' adjustments reflect the company's current and anticipated business dynamics, including the timing of deal closures and the potential impact on revenue growth.
Accolade also confirmed its fiscal year 2025 revenue guidance between $460 million to $475 million and projected a positive adjusted EBITDA of $15 million to $20 million. Despite concerns over delayed bookings, the company's revenue targets remain achievable with moderate growth in Annual Contract Value (ACV). Accolade's management has expressed optimism about a strong pipeline with diversification across employers, health plans, and government segments.
However, slower revenue growth is anticipated in fiscal year 2026 due to staggered launches. Despite these challenges, analyst firms have expressed confidence in Accolade's ability to meet performance guarantees and secure new business. These recent developments provide investors with a snapshot of Accolade's current financial health and future prospects as indicated by industry analysts.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.